GSK plc

GSK plc FCF per Share

The Free Cash Flow per Share of GSK plc (GSK.L) as of Oct 17, 2026 is 1.46 GBP. In the previous year, Free Cash Flow per Share was 0.86 GBP — a change of 69.12% (higher).

FCF per Share

1.46GBP

YoY

69.12%

Last updated:

Free Cash Flow per Share of GSK plc is 2025 1.46 GBP. Free Cash Flow per Share of GSK plc was 2024 0.86 GBP. It decreases by 69.12% higher compared to the previous year.

The GSK plc FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2018
1.66 GBP
Jan 1, 2019
1.46 GBP
Jan 1, 2020
1.54 GBP
Jan 1, 2021
1.55 GBP
Jan 1, 2022
1.26 GBP
Jan 1, 2023
1.07 GBP
Jan 1, 2024
0.86 GBP
Jan 1, 2025
1.46 GBP
The GSK plc FCF per Share history
YEARFCF per ShareYoY
1.46GBP+69.12%
0.86GBP-19.79%
1.07GBP-14.57%
1.26GBP-18.71%
1.55GBP+0.61%
1.54GBP+5.47%
1.46GBP-12.37%
1.66GBP+38.02%
1.21GBP+14.33%
1.05GBP+510.79%
0.17GBP-80.41%
0.88GBP—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

GSK plc Stock analysis

What does GSK plc do? GSK plc, listed on the London Stock Exchange under the ticker GSK.L, is a pharmaceutical company headquartered in Brentford, United Kingdom. The company, which has been publicly traded since May 22, 1972, operates within the healthcare sector, specifically in the pharmaceuticals industry. GSK employs 94,066 full-time staff, focusing on the research, development, and manufacturing of pharmaceutical medicines, vaccines, and consumer healthcare products. The company's operations are structured around two primary segments: Pharmaceuticals and Vaccines. In the Pharmaceuticals segment, GSK develops and markets medicines for a variety of conditions, including respiratory diseases, HIV and infectious diseases, immuno-inflammation, oncology, and rare diseases. The Vaccines segment provides immunization solutions for all age groups, from infants to the elderly, including pediatric, adolescent, adult, and travel vaccines. GSK's portfolio includes prescription medicines and vaccines, with a particular emphasis on respiratory and HIV-related treatments. The company's business strategy encompasses both innovative therapeutic areas and established product lines, supporting its global presence in healthcare. GSK's official website is www.gsk.com, offering further information about its products and initiatives. GSK plc is one of the most popular companies on Eulerpool.

Frequently Asked Questions about GSK plc stock

Free Cash Flow per Share of GSK plc is 1.46 GBP in 2025.

Free Cash Flow per Share of GSK plc changed from 0.86 GBP to 1.46 GBP, representing a 69.12% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share GSK plc since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — GSK plc

All Key Metrics — GSK plc